Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.

Canada communicable disease report = Relevé des maladies transmissibles au Canada

Volumn 27, Issue 3, 2001, Pages 21-24

  Hirji, Z ^a   O'Grady, S ^a   Bonham, J ^a   Mak, M ^a   Takata Shewchuk, J ^a   Hawkins, K ^a   Gardam, M ^a   Law, L ^a   Mazzulli, T ^a   Conly, J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GUANIDINE DERIVATIVE; PYRAN DERIVATIVE; SIALIC ACID DERIVATIVE; ZANAMIVIR;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INHALATIONAL DRUG ADMINISTRATION; MALE;

ADMINISTRATION, INHALATION; AGED; ANTIVIRAL AGENTS; FEMALE; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; PYRANS; SIALIC ACIDS; ZANAMIVIR;

EID: 0035259898     PISSN: 11884169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)